Smoking and liver cancer in China: Case-control comparison of 36,000 liver cancer deaths vs. 17,000 cirrhosis deaths

International Journal of Cancer

Volumn 107, Issue 1, 2003, Pages 106-112

  Chen, Zheng Ming ^a,d   Liu, Bo Qi ^b   Boreham, Jillian ^a   Wu, Ya Ping ^b   Chen, Jun Shi ^c   Peto, Richard ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b CANCER HOSPITAL   (China)

^c Centers for Disease Control   (China)

^d RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

China; Cirrhosis; HBV; Liver cancer; Smoking

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BLOOD ANALYSIS; CALCULATION; CANCER MORTALITY; CASE CONTROL STUDY; CHINA; CHRONIC HEPATITIS; CIGARETTE SMOKING; CITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GEOGRAPHIC DISTRIBUTION; HAZARD ASSESSMENT; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CANCER; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; RURAL AREA; SMOKING HABIT; STANDARDIZATION; STATISTICAL ANALYSIS;

ADULT; AGED; CASE-CONTROL STUDIES; CHINA; COHORT STUDIES; FEMALE; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SMOKING; SURVIVAL RATE;

EID: 0042916127     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.11342     Document Type: Article

References (42)

1. Li JY. Liu BQ, Li GY, Chen ZJ, Sun XD, Rong SD. Atlas of cancer mortality in the People's Republic of China: an aid for cancer control and research. Int J Epidemiol 1981;10:127-33.
2. Murray CJL, Lopez AD, eds. The global burden of disease and injury series. Vol 1. A comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990, and projected to 2020. Boston: Harvard School of Public Health, 1996.
3. Chen JS, Campbell TC, Li JY, Peto R. Diet, life-style and mortality in China: a study of the characteristics of 65 Chinese counties. Oxford: Oxford University Press, 1990, updated (2003) on www.ctsu.ox.ac.uk.
4. Beasley RP, Lin CC, Hwang LY, Chien CS. Hepatocellular carcinome and hepatitis B virus: a prospective study of 22 707 men in Taiwan. Lancet 1981;2:1129-32.
5. Ross RK, Yuan JM, Yu MC, Wogan GN, Qian GS, Tu JT, Groopman JD, Gao YT, Henderson BE. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet 1992;339:943-6.
6. Ming LH, Thorgeirsson SS, Gail MH, Lu PX, Harris CC, Wang NJ, Shao YF, Wu ZY, Liu GT, Wang XH, Sun ZT. Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China. Hepatology 2002;36:1214-20.
7. Trichopoulos D, MacMahon B, Sparros L, Merikas G. Smoking and hepatitis B-negative primary hepatocellular carcinoma. J Natl Cancer Inst 1980;65:111-4.
8. Yu MC, Mark T, Hanisch R, Peters RL, Henderson BE, Pike MC. Hepatitis, alcohol consumption, cigarette smoking, and hepatocellular carcinoma in Los Angeles. Cancer Res 1983;43:6077-9.
9. Austin H, Delzell E, Grufferman S, Levine R, Morrison AS, Stolley PD, Cole P. A case-control study of hepatocellular carcinoma and the hepatitis B virus, cigarette smoking, and alcohol consumption. Cancer Res 1986;46:962-6.
10. Doll R, Peto R, Wheatley K, Gray R, Sutherland I. Mortality in relation to smoking: 40 years' observations on male British doctors. Br Med J 1994;309:901-11.
11. McLaughlin JK, Hrubec Z, Blot WJ, Fraumeni JF. Smoking and cancer mortality among US veterans: a 26-year follow-up. Int J Cancer 1995;60:190-3.
12. International Agency for Research on Cancer. IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans: tobacco smoking. Vol 38. International Agency for Research on Cancer, Lyon, 1986.
13. Doll R, Peto R, Hall E, Wheatley K, Gray R. Mortality in relation to consumption of alcohol: 13 years' observations on male British doctors. Br Med J 1994;309:911-8.
14. Lam KC, Yu MC, Leung JWC, Henderson BE. Hepatitis B virus and cigarette smoking: risk factors for hepatocellular carcinoma in Hong Kong. Cancer Res 1982;42:5346-8.
15. Tu JT, Gao RN, Zhang DH, Gu BC. Hepatitis B virus and primary liver cancer on Chongming Island, People7apos;s Republic of China. Nat Cancer Inst Monogr 1985;69:213-5.
16. Lu SN, Lin TM, Chen CJ, Chen JS, Liaw YF, Chang WY, Hsu ST. A case-control study of primary hepatocellular carcinoma in Taiwan. Cancer 1988;42:872-6.
17. Chen CJ, Liang KY, Chang AS, Chang YC, Lu SN, Liaw YF, Chang WY, Sheen MC, Lin TM. Effects of hepatitis B virus, alcohol drinking, cigarette smoking and familial tendency on hepatocellular carcinoma. Hepatology 1991;13:398-406.
18. London WT, Evans AA, McGlynn K, Buetow K, An P, Gao L, Lustbader E, Ross E, Chen G, Shen F. Viral, host and environmental risk factors for hepatocellular carcinoma: a prospective study in Haimen City, China. Intervirology 1995;38:155-61.
19. Liu BQ, Peto R, Chen ZM, Boreham J, Wu YP, Li JY, Campbell TC, Chen JS. Emerging tobacco hazards in China. 1. Retrospective proportional mortality study of one million deaths. Br Med J 1998; 317:1411-22.
20. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719-48.
21. Armitage P, Berry G. Statistical methods in medical research, 2nd ed. Oxford: Blackwell Scientific, 1987.
22. Early Breast Cancer Trialist's Collaborative Group. Treatment of early breast cancer: Vol 1. Worldwide evidence 1985-1990. Oxford: Oxford Medical Publications, 1990.
23. Weng XZ, ed. Report on the 1984 Chinese national smoking prevalence survey. Beijing: People's Medical Publishing House, 1988.
24. Yuan JM, Ross RK, Wang XL, Gao YT, Henderson BE, Yu MC. Morbidity and mortality in relation to cigarette smoking: a prospective male cohort study in Shanghai, China. JAMA 1996;275:1646-50.
25. Chen ZM, Xu Z, Collins R, Li WX. Peto R. Early health effects of emerging tobacco epidemic in China: a 16-year prospective study. JAMA 1997;278:1500-4.
26. Liaw KM, Chen CJ. Mortality attributable to cigarette smoking in Taiwan: a 12-year follow-up study. Tobacco control 1998;7:141-8.
27. Chen CJ, Yu MW, Wang CJ. Multiple risk factors of hepatocellular carcinoma: a cohort study of 13,737 male adults in Taiwan. J Gastroenterol Hepatol 1993;8:S83-7.
28. Oshima A, Tsukuma H, Hiyama T, Fujimoto I, Yamano H, Tanaka M. Follow-up study of HbsAg-positive blood donors with special reference to effect of drinking and smoking on development of liver cancer. Int J Cancer 1984;34:775-9.
29. Kuper H, Tzonou A, Kaklamani E, Hsieh CC, Lagiou P, Adami HO, Trichopoulos D, Stuver SO. Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma. Int J Cancer 2000;85:498-502.
30. Mizoue T, Tokui N, Nishisaka K, Nishisaka SI, Ogimoto I, Ikeda M, Yoshimura T. Prospective study on the relation of cigarette smoking with cancer of the liver and stomach in an endemic region. Int J Epidemiol 2000;29:232-7.
31. , Sivri B, Barutca S. No relationship between smoking and hepatitis B virus-related hepatocellular carcinoma. Am J Gastroenterol 1997;92: 914.
32. International Agency for Research on Cancer. IARC Monographs on the evaluation of the carcinogenic risk of chemicals to humans: alcohol drinking. vol. 38:208-12. International Agency for Research on Cancer, Lyon, 1988.
33. Shibata A, Fukuda K, Toshima H, Tashiro H, Hirohata T. The role of cigarette smoking and drinking in the development of liver cancer: 28 years of observation on male cohort members in a farming and fishing area. Cancer Detect Prev 1990;14:617-23.
34. Yu MC, Tong MJ, Govindarajan S, Henderson BE. Nonviral risk factors for hepatocellular carinoma in a low-risk population, the non-Asians of Los Angeles County, California. J Natl Cancer Inst 1991;83:1820-6.
35. Ito S, Yao DF, Nii C, Horie T, Kamamura M, Nishikado T, Honda H, Shibato H, Shimizu T, Meng XY. Incidence of hepatitis C virus antibodies and HVC-RNA in blood donors and patients with liver diseases in the inshore area of the Yangtze River. J Gastroenterol Hepatol 1994;9:245-9.
36. Merican I, Guan R, Amarapuka D, Alexander MJ, Chutaputti A, Chien RN, Hasnian SS, Leung N, Lesmana L, Phiet PH, Sjalfoellah Noor HM, Sollano J, et al. Chronic hepatitis B virus infection in Asian countries. J Gastroenterol Hepatol 2000;15:1356-61.
37. Beasley RP. Hepatitis B virus: the major etiology o hepatocellular carcinoma. Cancer 1988;61:1942-56.
38. Zhang F, Zhu F, Sun ZT. Universal presence of HBVx gene and its close association with hotspot mutation of p53 gene in hepatocellular carcinoma of prevalent area in China. Chinese J Cancer 1998;20: 18-21 (in Chinese).
39. Wang LY, Chen CJ, Zhang YJ, Tsai WY, Lee PH, Feitelson MA, Lee CS, Santella RM. 4-Aminobiphenyl DNA damage in liver tissue of hepatocellular carcinoma patients and controls. Am J Epidemiol 1998; 147:315-23.
40. Yu MW, Pai CI, Yang SY, Hsiao TJ, Chang HC, Lin SM. Role of N-acetyltransferase polymorphisma in hepatitis B related hepatocellular carcinoma: impact of smoking on risk. Gut 2000;47:703-9.
41. Rivenson A, Hoffmann D, Prokopczyk B, Amin S, Hecht SS. Induction of lung and exocrine pancreas tumours in F344 rats by tobacco-specific and Areca-derived N-nitrosamnes. Cancer Res 1988;48:6912-7.
42. Yang GH, Fan LX, Tan J, Qi GM, Zhang YF, Samet JM, Taylor CE, Becker K, Xu J. Smoking in China: findings of the 1996 National Prevalence Survey. JAMA 1999;282:1247-53.